Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7
Authors
Keywords
IGF-1 receptor, Q640X, AR-V7, Castration-resistant prostate cancer
Journal
WORLD JOURNAL OF UROLOGY
Volume 34, Issue 5, Pages 633-639
Publisher
Springer Nature
Online
2015-08-28
DOI
10.1007/s00345-015-1674-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
- (2015) Yuanyuan Qu et al. Scientific Reports
- Androgen receptor phosphorylation: biological context and functional consequences
- (2014) Yulia Koryakina et al. ENDOCRINE-RELATED CANCER
- Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer
- (2014) Kathryn E Ware et al. ENDOCRINE-RELATED CANCER
- Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)
- (2014) Christian Rothermundt et al. EUROPEAN UROLOGY
- Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARΔLBD-Signalling in Human Prostate Cancer Cells
- (2014) Wolfgang Streicher et al. PLoS One
- Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors
- (2013) Feng Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Effects of Sorafenib on C-Terminally Truncated Androgen Receptor Variants in Human Prostate Cancer Cells
- (2012) Friedemann Zengerling et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation
- (2012) Shaoyong Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR variants in prostate cancer cells
- (2012) Wolfgang Streicher et al. WORLD JOURNAL OF UROLOGY
- Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
- (2011) Elahe A. Mostaghel et al. CLINICAL CANCER RESEARCH
- Post-translational modification of the androgen receptor
- (2011) Daniel Gioeli et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Serial analysis of resected prostate cancer suggests up-regulation of type 1 IGF receptor with disease progression
- (2010) Benjamin W. Turney et al. BJU INTERNATIONAL
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
- (2010) Shihua Sun et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells
- (2010) Xunxian Liu et al. PROSTATE
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
- (2008) R. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More